The relationship between medical cannabis users and insurance companies is a saga. The issue surrounding the insurance companies and medical marijuana not being covered with the insurance begins with the FDA. In the United States, cannabis is not accepted on a federal level as a drug for medical use. The lack of the stamp of approval for cannabis from the FDA places a huge barrier between the insurance companies and their coverage of medical marijuana under health insurance. This places Medicare which attends to the federal health of senior citizens and Medicaid which attends to the federal health of low-income citizens in a tight spot when it comes to medical marijuana. The lack of approval of cannabis on a federal level by the FDA also puts private health insurance companies in a bind and keeps them from covering it.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…